Michael Demaray is principal and founder of Elevated Capital LLC. He focuses on investing in companies in relation to their intrinsic value. He is a CFA charterholder and member of the CFA Society of Chicago.
His comments on SeekingAlpha represent his personal opinions and should neither be construed as the views and opinions of Elevated Capital LLC and its affiliated funds, nor an offer or solicitation to buy or sell any security, nor investment advice of any kind.
I mainly trade mean-reversion strategies, specifically in the deep value space, but my fund is unconstrained and explores the entire asset class universe, looking for unexplored and underpriced opportunities across all investible sectors.
Adam Gefvert is the head analyst for White Diamond Research, a research firm for hedge funds and high net worth individuals. You can read those reports at whitediamondresearch.com.
Primarily a short seller, he has saved investors millions of dollars by exposing highly overvalued small cap stocks. He has a 90%+ success rate with his Seeking Alpha short ideas. He specializes in technology, energy, and biotech stocks, because those are the sectors with the greatest valuation inefficiencies. You can follow Adam on twitter @shiningboy
Follow White Diamond Research on twitter @whiteresearch
Volte-Face Investments represents the writings of an independent investment manager who managed a long/short equity fund. The author worked for a major Wall Street firm for 12 years before leaving to start his own business in 2009. Since then he has been pursuing investment management full time. The purpose of the articles is to explain the thinking with regards to a particular investment opportunity and to provide readers with a foundation from which they can begin their own due diligence. Volte-Face Investment's writings are not solicitations to transact any security. For further information or consulting, please contact via direct message or direct message on twitter @voltefaceinvest
I've been investing in stocks since I was 12 years old and have a knack for picking out disruptive technologies including 3D printing and OLED screens in their infancy (since 2006). I have a strong education in biology, physiology, chemistry, IT and software. This enables me to be successful in Biotech, Technology, and Social Media stocks as well. I have developed software solutions for major fortune 500 companies.